Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
ProShares Short VIX Short-Term Futures ETF
SVXY
$202M
| $502K | ﹤0.01% |
11,620
+5,810
| +100% | +$252K |
|
2727
Vita Coco
COCO
$3.73B
| $501K | ﹤0.01% |
19,258
+9,019
| +88% | +$241K |
|
2728
Metallus
MTUS
$897M
| $501K | ﹤0.01% |
23,049
-48,290
| -68% | -$1.05M |
|
2729
Driven Brands
DRVN
$2.45B
| $500K | ﹤0.01% |
39,702
+25,427
| +178% | +$465K |
|
2730
Anika Therapeutics
ANIK
$262M
| $499K | ﹤0.01% |
26,765
+2,209
| +9% | +$45.8K |
|
|
INFA
2731
DELISTED
Informatica
INFA
| $498K | ﹤0.01% |
23,615
-1,326
| -5% | -$26.4K |
|
2732
National Presto Industries
NPK
$975M
| $496K | ﹤0.01% |
6,851
+2,183
| +47% | +$165K |
|
|
TBRG
2733
DELISTED
TruBridge
TBRG
| $496K | ﹤0.01% |
31,096
+20,918
| +206% | +$427K |
|
2734
Liberty Latin America Class C
LILAK
$1.67B
| $496K | ﹤0.01% |
66,806
-7,711
| -10% | -$59.4K |
|
|
BSCN
2735
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $495K | ﹤0.01% |
23,300
| – | – |
|
2736
AMC Global Media
AMCX
$501M
| $494K | ﹤0.01% |
41,906
+26,061
| +164% | +$316K |
|
2737
WisdomTree Japan Hedged Equity Fund
DXJ
$7.2B
| $491K | ﹤0.01% |
5,564
-654
| -11% | -$55.8K |
|
|
XIFR
2738
XPLR Infrastructure LP
XIFR
$1.11B
| $489K | ﹤0.01% |
16,477
-11,201
| -40% | -$567K |
|
2739
Cimpress
CMPR
$2.49B
| $487K | ﹤0.01% |
6,953
-169
| -2% | -$11.2K |
|
2740
Cullinan Oncology
CGEM
$1.08B
| $483K | ﹤0.01% |
53,393
+31,650
| +146% | +$330K |
|
2741
Safety Insurance
SAFT
$1.52B
| $482K | ﹤0.01% |
7,064
-356
| -5% | -$24.8K |
|
2742
Peapack-Gladstone Financial
PGC
$827M
| $480K | ﹤0.01% |
18,722
-1,812
| -9% | -$50.1K |
|
2743
Medifast
MED
$145M
| $479K | ﹤0.01% |
6,402
-1,365
| -18% | -$121K |
|
2744
Shenandoah Telecom
SHEN
$742M
| $479K | ﹤0.01% |
23,222
-2,687
| -10% | -$55K |
|
2745
Kearny Financial
KRNY
$613M
| $478K | ﹤0.01% |
69,046
-7,812
| -10% | -$59.3K |
|
2746
Methode Electronics
MEI
$536M
| $478K | ﹤0.01% |
20,915
+1,400
| +7% | +$41.7K |
|
2747
Crescent Energy
CRGY
$3.73B
| $477K | ﹤0.01% |
37,727
+15,827
| +72% | +$194K |
|
|
SEMR
2748
DELISTED
Semrush
SEMR
| $474K | ﹤0.01% |
55,756
+3,914
| +8% | +$36.5K |
|
2749
iRadimed
IRMD
$1.19B
| $473K | ﹤0.01% |
10,656
+3,203
| +43% | +$149K |
|
2750
QuinStreet
QNST
$898M
| $471K | ﹤0.01% |
52,545
+15,215
| +41% | +$141K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.